Not only Pfizer, Modern e AstraZeneca, Italy could have available five vaccines before Easter. This was revealed by Armando Genazzani, member of the Committee for Medical Products for Humans Use (CHMP) of EMA, during an interview with the program Good morning di SkyTG24. According to Genazzani: "on February XNUMXst of last year we hardly imagined that a virus could hit us and we never imagined this pandemic. We now have three of vaccines available. Johnson & Johnson has released a press release in which it begins to release data on its vaccine. It is effective after a single dose. novavax it is particularly advanced, so if I said earlier that we would have four vaccines before Easter, now I think it may even be five».
Five vaccines before Easter, but herd immunity is still a long way off
The availability of five vaccines in Italy before Easter is certainly good news for Italy vaccine plan. In fact, due to distribution problems, the "vaccination machine" is proceeding slowly. Fortunately, however, in addition to the arrival of the Johnson & Johnson e novavax, more good news has come from Pfizer-Biontech e AstraZeneca. The US company announced that it will deliver in the second quarter 75milioni of doses additional in EU countries, while the British pharmaceutical company will deliver 9 million doses more already in the first quarter. The AstraZeneca vaccine, which Dr. Genazzini defined "series A ", at the moment it will still be administered to during 55. The idea is to already use the first million doses arriving in February for teachers, in prisons, For police and the workers of the public services, or the categories most exposed to the Covid-19. Of course, nothing has yet been confirmed.
Despite all the good news coming, it must always be considered that we are still far from the main goal, which is to reach theherd immunity. According to the rosiest forecasts, this could come after summer. Unfortunately, the recent delays and the use of the AstraZeneca vaccine only for the under 55s, makes it postpone by a few months, perhaps at the beginning of the 2022. If theEMA really authorize the Johnson & Johnson and Novavax vaccines in the coming weeks, there may still be a few more chances to reach the goal. We just have to hope for more good news to arrive.
